The most widely tested inflammatory biomarker is high-sensitivity C-reactive protein (hs-CRP), which predicts the risk of a first MI in healthy individuals and future coronary events in patients with stable CAD [7]. This evidence concerns the gene CRP and coronary artery disorder.